Compare PLBY & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLBY | OSUR |
|---|---|---|
| Founded | 1953 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.6M | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | PLBY | OSUR |
|---|---|---|
| Price | $1.92 | $2.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $3.00 | $3.00 |
| AVG Volume (30 Days) | 493.5K | ★ 661.1K |
| Earning Date | 11-12-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $119,510,000.00 | ★ $125,703,000.00 |
| Revenue This Year | $4.97 | N/A |
| Revenue Next Year | $8.38 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.90 | $2.08 |
| 52 Week High | $2.53 | $4.22 |
| Indicator | PLBY | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 54.65 | 60.17 |
| Support Level | $1.82 | $2.55 |
| Resistance Level | $2.04 | $2.81 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 53.85 | 76.84 |
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.